Further analysis of the correlation between TGFβ1 expression and clinical pathological parameters in GC patients revealed significant differences in TGFβ1 expression levels between T1 and T2-T4 stages (Fig. 1e). This evidence concerns the gene TGFB1 and gastric cancer.